MDSpire - Takeaway
Feature

Metformin’s Potential Role in Posterior Capsule Opacification

Common diabetes therapy reaches intraocular lens tissue and may help limit PCO, says newly published data

  • March 30, 2026

  • 3 min

Share

  • 1

    Metformin may reduce the risk of posterior capsule opacification (PCO) after cataract surgery.

  • 2

    PCO occurs in 20-30% of patients within five years.

  • 3

    Nd:YAG laser capsulotomy treats PCO but has risks.

  • 4

    Metformin suppresses lens epithelial cell proliferation.

  • 5

    Study involved 20 patients with diabetes.

  • 6

    Metformin levels correlate in serum and lens capsule.

  • 7

    Larger studies are needed for confirmation.

Original Source(s)

Metformin’s Potential Role in Posterior Capsule Opacification

  • March 30, 2026

Related Content

Decoding Idiopathic Intracranial Hypertension

Marc Bouffard discusses Mass General Brigham’s recently launched initiative aimed at better understanding idiopathic intracranial hypertension

Farid Takes Helm of Aurion MAB

Aurion Biotech names Marjan Farid chair of medical advisory board

  • March 27, 2026

  • 2 min
Why Proactive Dry Eye Care Should Be the New Standard

The dental profession long ago decided it was important to preach preventative maintenance for everyone. We should do the same